SCHEMBL6087158

SCHEMBL6087158

CC(C)C1C(O)=CCc2cnc(Nc3ccc(N4CC5=CN(C)CC5C4)cc3)nc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 7/20 0.36
KDR P35968 5/20 0.35
RPS6KA6 Q9UK32 1/20 0.35
CDK4 P11802 4/20 0.35
CCND1 P24385 3/20 0.35
CCND2 P30279 3/20 0.35
CCND3 P30281 3/20 0.35
CDK2 P24941 3/20 0.35
CDK1 P06493 2/20 0.35
CCNE2 O96020 2/20 0.35
CCNA2 P20248 2/20 0.35
CCNE1 P24864 2/20 0.35
CCNA1 P78396 2/20 0.35
CCNB2 O95067 1/20 0.35
FGFR1 P11362 1/20 0.35
CCNB1 P14635 1/20 0.35
FGFR2 P21802 1/20 0.35
FGFR4 P22455 1/20 0.35
FGFR3 P22607 1/20 0.35
CCNB3 Q8WWL7 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6087733 0.88 EGFR (0.39) EGFRKDRCDK4CCND1CDK2
SCHEMBL6087814 0.85 CDK4 (0.39) EGFRKDRCDK4CCND1CCND2
SCHEMBL6087151 0.84 CDK4 (0.41) EGFRKDRRPS6KA6CDK4CCND1
SCHEMBL6090969 0.82 CDK4 (0.46) EGFRKDRRPS6KA6CDK4CCND1
SCHEMBL6087196 0.80 CDK4 (0.49) RPS6KA6CDK4CCND1CCND2CCND3
SCHEMBL6088805 0.80 CDK4 (0.51) EGFRKDRCDK4CCND1CCND2
SCHEMBL6086935 0.78 IGF1R (0.41) CDK4CCND1CCND3CDK2CDK1
SCHEMBL6087486 0.78 ALK (0.56) CDK4CCND1CDK2CCNE1ALK
SCHEMBL6087067 0.77 CDK2 (0.44) EGFRKDRCDK4CCND1CCND2
SCHEMBL6086866 0.77 CDK4 (0.39) EGFRKDRCDK4CCND1CCND2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1235815-A1 QUINAZOLINES AND THEIR USE FOR INHIBITING CYCLIN-DEPENDENT KINASE ENZYMES WARNER-LAMBERT COMPANY (US) 2002-09-04 EP claimed
WO-2001038315-A1 QUINAZOLINES AND THEIR USE FOR INHIBITING CYCLIN-DEPENDENT KINASE ENZYMES WARNER-LAMBERT COMPANY (US) 2001-05-31 WO claimed
US-6982260-B1 Quinazolines and their use for inhibiting cyclin-dependent kinase enzymes WARNER-LAMBERT COMPANY (US) 2006-01-03 US disclosed
EP-1235815-A1 QUINAZOLINES AND THEIR USE FOR INHIBITING CYCLIN-DEPENDENT KINASE ENZYMES WARNER-LAMBERT COMPANY (US) 2002-09-04 EP disclosed
WO-2001038315-A1 QUINAZOLINES AND THEIR USE FOR INHIBITING CYCLIN-DEPENDENT KINASE ENZYMES WARNER-LAMBERT COMPANY (US) 2001-05-31 WO disclosed